CompletedPhase 3NCT02066181
Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Studying Desmoid tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Mrinal M Gounder, M.DAlliance for Clinical Trials in Oncology
- Intervention
- Laboratory Biomarker Analysis(other)
- Enrollment
- 87 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2022
Study locations (30)
- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- PCR Oncology, Arroyo Grande, California, United States
- Yale University, New Haven, Connecticut, United States
- Beebe Medical Center, Lewes, Delaware, United States
- Christiana Gynecologic Oncology LLC, Newark, Delaware, United States
- Delaware Clinical and Laboratory Physicians PA, Newark, Delaware, United States
- Helen F Graham Cancer Center, Newark, Delaware, United States
- Medical Oncology Hematology Consultants PA, Newark, Delaware, United States
- Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States
- Beebe Health Campus, Rehoboth Beach, Delaware, United States
- TidalHealth Nanticoke / Allen Cancer Center, Seaford, Delaware, United States
- Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware, United States
- MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States
- MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02066181 on ClinicalTrials.govOther trials for Desmoid tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07541430A Study in Adults With Desmoid TumorsElpiscience (Suzhou) Biopharma, Ltd.
- RECRUITINGPHASE4NCT07176689Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- ACTIVE NOT RECRUITINGPHASE2NCT07170644A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- RECRUITINGNCT06945887Treatment of Desmoid Fibromatosis With Arterial EmbolizationIstituto Ortopedico Rizzoli
- RECRUITINGNCT07496242Immunological Phenotype of Desmoid-fibromatosis-affected Patients.Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- RECRUITINGPHASE2NCT05879146Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical StudyM.D. Anderson Cancer Center
- RECRUITINGNCT06660121Electrochemotherapy for Desmoid TumorsIstituto Ortopedico Rizzoli
- RECRUITINGNANCT06081400Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful WaitingUniversity Hospital, Strasbourg, France